On ECHEMI
Home > Drugs > Ciprofloxacin hydrochloride eye drops

Ciprofloxacin hydrochloride eye drops

Function and Efficacy

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

Ingredients

Ciprofloxacin hydrochloride. Its chemical name is: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride monohydrate.

Name Description Content CAS NO. Manufacturer
Ciprofloxacin hydrochlorideIngredients

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More
93107-08-5 37

Appearance

This product is a colorless or slightly yellow clear liquid.

Indication

Used for external eye infections caused by sensitive bacteria (such as conjunctivitis, etc.).

Usage and Dosage

Apply inside the eyelid, 1 to 2 drops at a time, 3 to 6 times a day, for 6 to 14 days.

Adverse Reactions

Occasionally, there are transient local irritation symptoms. Local burning and foreign body sensation may occur. In addition, eyelid edema, tearing, photophobia, decreased vision, and allergic reactions are less common.

Precautions

Patients who are allergic to this product and quinolones are contraindicated.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Long-term and excessive use, after local absorption, can produce the same drug interactions as systemic medications, such as increasing the blood concentrations of drugs such as theophylline, cyclosporine, and probenecid, enhancing the anticoagulant effect of the anticoagulant warfarin, and interfering with the metabolism of caffeine.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

5ml:15mg(calculated as C17H18FN3O3)

Validity Period

24 months

Manufacturer

Hubei Qianjiang Pharmaceutical Co., Ltd.

  • Founded in:

    2009-09-18
  • Address:

    No. 1, Zhanghua South Road, Qianjiang City
  • Tax NO.:

    91429005695102248D
  • Registered Funds:

    300 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.